DUBLIN, Aug. 25, 2025 /PRNewswire/ -- ProVerum Limited, the developer of the ProVee® System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH), announced today the ...
NEW TECHNOLOGY: The new HYDROS™ Robotic System is the next-generation platform to treat men suffering from benign prostatic hyperplasia. (Submitted Photo) THOMASVILLE — Archbold is now offering ...
ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...
Year DurabilityInnovative Design Allows for Only Tailored BPH Approach that Preserves Natural AnatomySOUTH SAN ...
DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it ...
IRVINE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NYMXF) [OTC Markets – NYMXF] (the “Company”) is pleased to announce today that a new formal submission has been ...
Profound Medical Corp. (NASDAQ:PROF) is one of the best Canadian stocks with huge upside potential. On June 10, Profound Medical announced the successful completion of the first commercial benign ...
NEW BERN, N.C. (WNCT) — The Urology team at CarolinaEast Health System announced they are offering A quablation therapy and have completed their 100th treatment. A quablation therapy treats the lower ...